MedTrace Logo

Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders

NCT01875796 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2016-08-25

No results posted yet for this study

Summary

This project tests the feasibility and utility of a novel, integrated approach to treatment of patients with cannabis use disorder (CUD) and anxiety disorders.

Conditions

  • Cannabis Dependence
  • Anxiety Disorders
  • Cannabis Use Disorder
  • Cannabis Abuse

Interventions

BEHAVIORAL

Cognitive-Behavioral Therapy

BEHAVIORAL

Motivation Enhancement Therapy

BEHAVIORAL

Integrated Cannabis and Anxiety Reduction Treatment

BEHAVIORAL

False Safety Behavior Elimination Therapy

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Louisiana State University and A&M College

    lead OTHER

Principal Investigators

  • Julia D Buckner, PhD · Louisiana State University Health Sciences Center in New Orleans

  • Michael J Zvolensky, PhD · University of Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01875796 on ClinicalTrials.gov